CD44 and urinary bladder cancer: Other studies using PDX models of bladder cancer have demonstrated that CD49f, in conjunction with surface antigens such as CD44, CK20, CD4714, and CD9015, discriminate poorly differentiated (basal) from differentiated bladder cancer cells.